Results 121 to 130 of about 779,609 (165)

Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials. [PDF]

open access: yesBioDrugs, 2020
Jørgensen KK   +28 more
europepmc   +1 more source

Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease

open access: yesGastroenterology, 2021
BACKGROUND AIMS: This study compared pharmacokinetics, symptomatic and endoscopic efficacy, safety, and immunogenicity of a subcutaneous formulation of the infliximab biosimilar CT-P13 (CT-P13 SC) vs intravenous CT-P13 (CT-P13 IV) in patients with ...
Byong Duk Ye   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy